Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

BSX Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: June 01, 2026

Report Source: 2026 1st Quarter Report

Analyst's Ratings for Boston Scientific Corp (BSX)

Based on 40 analysts giving stock ratings to Boston Scientific Corp in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
35
Buy
57
Hold
8
Sell
0
Strong Sell
0
Boston Scientific Corp

Boston Scientific Corp. Stock Analysis BSX

United States Health Care Large Cap Report:
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. The company is headquartered in Marlborough, Massachusetts and currently employs 59,000 full-time employees. The firm's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.
Read More

Boston Scientific Corp (BSX) Chart

Key Statistics of Boston Scientific Corp (BSX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$44.40$45.69

Today's Open

$44.63

Volume

18.70M

P/E Ratio (TTM)

23.03

52 Week Range

$44.05$109.50

Market Cap

84.95B

Avg. Volume

22.70M

Dividend Yield

-

Financial Metrics & Statements of Boston Scientific Corp (BSX)

FAQ's for Boston Scientific Corp (BSX)

  • According to Musaffa’s Shariah screening methodology, Boston Scientific Corp (BSX) is currently classified as HALAL as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Boston Scientific Corp using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Boston Scientific Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Boston Scientific Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Boston Scientific Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Boston Scientific Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.